RENO, Nev.–(BUSINESS WIRE)–Anthem Blue Cross and Blue Shield in Nevada announced today expanded access to health and wellness services offered through many of its 2022 Medicare Advantage plans. Members will be able to choose from a package of up to n…
Author: Business Wire
Anthem Blue Cross and Blue Shield Increases Access to Whole-Health Benefits in Medicare Advantage Plans to Meet Members’ Unique Healthcare Needs
WALLINGFORD, Conn.–(BUSINESS WIRE)–Anthem Blue Cross and Blue Shield in Connecticut announced today expanded access to health and wellness services offered through many of its 2022 Medicare Advantage plans. Members will be able to choose from a packa…
Anthem Blue Cross and Blue Shield Increases Access to Whole-Health Benefits in Medicare Advantage Plans to Meet Members’ Unique Healthcare Needs
INDIANAPOLIS–(BUSINESS WIRE)–Anthem Blue Cross and Blue Shield in Indiana announced today expanded access to health and wellness services offered through many of its 2022 Medicare Advantage plans. Members will be able to choose from a package of up t…
Opportunities in the Global Eyewear Market: A $111.12 Billion Market by 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eyewear Market, By Product Type (Sunglasses Spectacles, Contact Lenses, Sport Eyewear, and Others (Safety Eyewear & Protection Eyewear)), By End User (Women, Men, and Unisex), By Distribution Channel, By Region …
ROCCAT and Oakley Launch a New Limited-Edition ROCCAT PC Gaming Eyewear Collection
WHITE PLAINS, N.Y. & FOOTHILL RANCH, Calif.–(BUSINESS WIRE)–ROCCAT x Oakley Partnership Announcement
Promising New OpRegen® Clinical Data Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, reported today th…
RIBOMIC Announces Presentation of Masked Preliminary Interim Data from Phase 2 Trials of RBM-007 for Wet Age-Related Macular Degeneration at the Retina Society 2021 Meeting
TOKYO–(BUSINESS WIRE)–RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics (TOKYO:4591), today announced the presentation of preliminary interim results from the ongoing two Phase 2 studies, TOFU and the RAMEN e…
Gyroscope Therapeutics Announces Presentation of Positive Interim Phase I/II Data for Investigational Gene Therapy GT005 at Retina Society Annual Scientific Meeting
LONDON–(BUSINESS WIRE)–Gyroscope Therapeutics announces positive interim phase I/II data for investigational gene therapy GT005 at Retina Society Annual Scientific Meeting.
Inflammasome Therapeutics’ Kamuvudines Continue to Show Promise for Future Treatment – and Potentially a Cure – for Blindness in Seniors
NEWTON, Mass.–(BUSINESS WIRE)– #AMD–New research points to Inflammasome’s Kamuvudines Continue to Show Promise for Future Treatment – and Potentially Cure – for Blindness in Aged
The Retina Center of Charleston Joins the US Eye Network
CHARLESTON, S.C.–(BUSINESS WIRE)– #Eyecare–Dr. Lowrey King, founder of The Retina Center of Charleston, has joined the US Eye network.
Isarna Therapeutics Appoints Claus Schalper as CEO
MUNICH–(BUSINESS WIRE)–Isarna Therapeutics today announced the appointment of Claus Schalper as Chief Executive Officer. Mr. Schalper joins Isarna with over 20 years of experience as an executive and serial entrepreneur in the life science and biotec…
Celera Motion Introduces Ultra-Lightweight Inductive Angle Encoder
BEDFORD, Mass.–(BUSINESS WIRE)–Celera Motion, an award-winning business unit of Novanta Inc., announced today another innovative new device for precise angle measurement: a compact, ultra-lightweight inductive angle encoder, ideal for a variety of su…
Global Shaft Measurement & Inspection Solutions Industry Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Shaft Measurement & Inspection Solutions Industry Growth Opportunities, 2021” report has been added to ResearchAndMarkets.com’s offering. This research service analyzes the global trends in the optical shaft met…
Aura Biosciences Expands Executive Leadership Team and Board of Directors
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the appointment of Chris Primiano, J.D., as …
NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of DERMAdoctor
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that management will discuss its acquisition of DERMAdoctor on an investment community conference call and webcast with accompanying slide presentation t…
Warby Parker Announces Update Regarding Conversion of Shares of Class B Common Stock to Shares of Class A Common Stock
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (the “Company”), a founder-led direct-to-consumer eyewear brand, today announced that, as of September 28, 2021, the Company had 111.5 million shares of Common Stock outstanding, consisting of 92.5 million s…
U.S.Vision Launches JCPenney Optical “Eyes on the Prize” Sweepstakes
BLACKWOOD, N.J.–(BUSINESS WIRE)–U.S.Vision announced the JCPenney Optical “Eyes on the Prize” sweepstakes.
NovaBay Pharmaceuticals Signs Agreement to Acquire DERMAdoctor
EMERYVILLE, Calif.–(BUSINESS WIRE)—- $NBY #DERMAdoctor–NovaBay Pharmaceuticals Signs Agreement to Acquire DERMAdoctor
Ocular Therapeutix™ Announces Appointment of Karen-Leigh Edwards as Senior Vice President of Technical Operations
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Alcon Honored with FutureEdge 50 Award
FORT WORTH, Texas–(BUSINESS WIRE)–Alcon Honored with FutureEdge 50 Award